1. "Improving the performance of Bayesian logistic regression model with overdose control in oncology dose‐finding studies" by Hongtao Zhang, Alan Chiang, and Jixian Wang. (17th November 2022) Authors: Iasonos, Alexia; Wheeler, Graham M. Journal: Statistics in medicine Issue: Volume 41:Number 27(2022) Page Start: 5494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2 × 2 Tables: a note on Campbell's recommendation. (17th November 2015) Authors: Busing, F. M. T. A.; Weaver, B.; Dubois, S. Journal: Statistics in medicine Issue: Volume 35:Number 8(2016) Page Start: 1354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A 3‐level Bayesian mixed effects location scale model with an application to ecological momentary assessment data. (26th February 2018) Authors: Lin, Xiaolei; Mermelstein, Robin J.; Hedeker, Donald Journal: Statistics in medicine Issue: Volume 37:Number 13(2018) Page Start: 2108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A balanced hazard ratio for risk group evaluation from survival data. (20th April 2015) Authors: Branders, Samuel; Dupont, Pierre Journal: Statistics in medicine Issue: Volume 34:Number 17(2015) Page Start: 2528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials. (7th April 2016) Authors: Tighiouart, Mourad; Li, Quanlin; Rogatko, André Other Names: Cheung Ken guestEditor.; Iasonos Alexia guestEditor.; Jaki Thomas guestEditor.; O'Quigley John guestEditor. Journal: Statistics in medicine Issue: Volume 36:Number 2(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Bayesian adaptive dose selection procedure with an overdispersed count endpoint. (11th September 2013) Authors: Pozzi, L.; Schmidli, H.; Gasparini, M.; Racine‐Poon, A. Journal: Statistics in medicine Issue: Volume 32:Number 28(2013) Page Start: 5008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Bayesian adaptive marker‐stratified design for molecularly targeted agents with customized hierarchical modeling. (9th April 2019) Authors: Zang, Yong; Guo, Beibei; Han, Yan; Cao, Sha; Zhang, Chi Journal: Statistics in medicine Issue: Volume 38:Number 15(2019) Page Start: 2883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials. (22nd October 2020) Authors: Mu, Rongji; Pan, Haitao; Xu, Guoying Journal: Statistics in medicine Issue: Volume 40:Number 2(2021) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Bayesian adaptive phase I–II trial design for optimizing the schedule of therapeutic cancer vaccines. (21st August 2016) Authors: Cunanan, Kristen M.; Koopmeiners, Joseph S. Journal: Statistics in medicine Issue: Volume 36:Number 1(2017) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Bayesian analysis of quantal bioassay experiments incorporating historical controls via Bayes factors. (20th January 2017) Authors: León Novelo, Luis G.; Womack, Andrew; Zhu, Hongxiao; Wu, Xiaowei Journal: Statistics in medicine Issue: Volume 36:Number 12(2017) Page Start: 1907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗